Tobacco Use Disorder Clinical Trial
Official title:
CHERL, Connecting Primary Care Patients With Community Resources to Facilitate Behavior Change
The investigators want to find out if providing a Community Health Educator Referral Liaison (CHERL) helps practices help their patients change risky behaviors (tobacco use, physical inactivity, unhealthy diet, and risky drinking) by connecting patients to available services in the community or directly providing behavior change support.
What is this about? Prescription for Health (P4H) is a national initiative funded by the
Robert Wood Johnson Foundation. Nine projects have been funded nationally in this second
round to advance the goals of improving health behavior identification and delivery in
primary care practice. Each project is conducted through a practice-based research network
(PBRN). In Michigan, our PBRN is called the Great Lakes Research In Practice Network (GRIN).
What is the purpose of the CHERL project? In our study, we want to find out if providing a
Community Health Educator Referral Liaison (CHERL) helps practices help their patients
change risky behaviors (tobacco use, physical inactivity, unhealthy diet, and risky
drinking) by connecting patients to available services in the community or directly
providing behavior change support.
Primary care providers play a key roll in encouraging patients to choose healthy behaviors.
However, effective behavior change requires long term follow up and support that may not be
readily available within the office practice. CHERL can help provide or link to those
services thus helping the healthy message promoted by the clinician to have a more powerful
and lasting effect.
What is the CHERL intervention? With this funding, we will hire and train a CHERL to work
with practices. The purpose of the CHERL is for him/her to help secure behavior change
support for your patients either by referring to an available resource within the community
or directly providing the service. This service is available to patients with or without
chronic disease diagnoses (i.e, patients with diabetes, heart disease, hypertension,
obesity, back pain, lung disease, or generally healthy with opportunities to change
unhealthy habits).
Patients are referred to the CHERL and he/she will determine an appropriate next step for
your patient – either referral to a community program or the CHERL will provide brief
telephone counseling. The health care provider will receive feedback specifically on each
patient referred.
In addition, some practices (consultant-enhanced) will receive additional assistance from
the CHERL, as he/she serves as a consultant to the practice, helping the practice to
identify systematic mechanisms for identification and referral of at risk patients to the
CHERL.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Educational/Counseling/Training
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02432066 -
Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
|
Phase 2 | |
Completed |
NCT03960138 -
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Completed |
NCT04646668 -
Comparative Abuse Liability Among African American and White Smokers
|
N/A | |
Completed |
NCT02560324 -
Effect of Ramelteon on Smoking Abstinence
|
Phase 2 | |
Completed |
NCT02347605 -
Medicinal Nicotine for Preventing Cue Induced Craving
|
N/A | |
Completed |
NCT01625767 -
Tobacco Approach Avoidance Training for Adolescent Smokers-1
|
Phase 2 | |
Completed |
NCT01442753 -
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth
|
N/A | |
Completed |
NCT01428310 -
Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
|
Phase 1 | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Terminated |
NCT01800500 -
Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers
|
N/A | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT01337817 -
A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers
|
Phase 1 | |
Completed |
NCT00967005 -
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
|
Phase 2 | |
Active, not recruiting |
NCT00751660 -
Screening Methods in Finding Lung Cancer Early in Current or Former Smokers
|
N/A | |
Completed |
NCT00790569 -
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
|
N/A | |
Completed |
NCT00664261 -
Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking
|
N/A | |
Completed |
NCT00218179 -
Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1
|
N/A | |
Completed |
NCT00134927 -
A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches
|
N/A | |
Completed |
NCT00158145 -
Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2
|
Phase 2 |